Stay updated with breaking news from Adicet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on October 31,... | October 31, 2022
WASHINGTON (dpa-AFX) - Adicet Bio, Inc. (ACET) reported a second quarter net loss attributable to common shareholders of $22.5 million, or a net loss of $0.56 per share, as compared to a net loss
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, today announced it granted inducement awards on May 31,... | June 3, 2022
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor T cell therapies for cancer, today announced the... | April 19, 2022
WASHINGTON (dpa-AFX) - Adicet Bio, Inc (ACET) released Loss for its fourth quarter that increased from last year and missed the Street estimates.The company's earnings totaled -$15.81 million,